drugset / Trial / NCT00377260

Acute Otitis Media (AOM) Therapy Trial in Young Children

NCT00377260 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to learn whether or not all children with ear infections (acute otitis media or AOM) should be treated with antibiotics. The study will compare two treatment strategies, "watchful waiting" or treatment with antibiotics, to determine which is more appropriate for children with AOM. About 268 children in Pittsburgh, between the ages of 6-23 months, with AOM will be enrolled in the study. They will be treated either with Augmentin (an antibiotic) or placebo for 10 days and closely followed for about 1 month. Parents will be asked to write information about their child in a Patient Diary. A general physical exam, including an ear exam, will be performed 4 times during the study. A mucus sample will be collected from the back of each child's nose. Parents will be asked questions during phone calls and at every visit. If a child has not improved or has worsened, the investigators will prescribe a different antibiotic that is known to kill resistant germs.

Timeline

Start
2006-11
Primary completion
2009-04
Completion
2009-04

Outcome

Mixed primary results

registry analysis (superiority or other test); Amoxicillin-Clavulanate vs Placebo; p = .14; Hazard Ratio (HR) 1.22; Regression, Cox NCT00377260 ↗

registry analysis (superiority or other test); Amoxicillin-Clavulanate vs Placebo; p = .04; Hazard Ratio (HR) 1.37; Regression, Cox NCT00377260 ↗

registry analysis (superiority or other test); Amoxicillin-Clavulanate vs Placebo; p = .01; Regression, Linear NCT00377260 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin-clavulanate Other / unclassified 90 mg/kg —

Indications